| Product NDC: | 60977-116 | 
| Proprietary Name: | Ativan | 
| Non Proprietary Name: | lorazepam | 
| Active Ingredient(s): | 2 mg/mL & nbsp; lorazepam | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 60977-116 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA018140 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20090924 | 
| Package NDC: | 60977-116-02 | 
| Package Description: | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) | 
| NDC Code | 60977-116-02 | 
| Proprietary Name | Ativan | 
| Package Description | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) | 
| Product NDC | 60977-116 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | lorazepam | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20090924 | 
| Marketing Category Name | NDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | LORAZEPAM | 
| Strength Number | 2 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |